The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'd like to ask why they aren't looking at a dual listing if current funding isnt an issue, rather than close and then relist (maybe) on an American Market.
This would give investors more confidence they won't lose everything as it appears there is no guarantee of ever relisting.
Also JP Jenkins tends to be very illiquid so hardly likely to be able to trade so why should this be considered helpful?
Someone is buying them all, bit odd
Hello, this is Mark from StockBox. I will be interviewing Clarissa in an hour. This news has obviously come as a surprise and if anyone has any questions you'd like asking post here and I'll put them accross.
Exactly..
“In due course, the Company expects to re-list on a regulated investment exchange that recognises the true underlying value of the business. We remain a British company, and we are proud to be part of the UK life sciences sector and believe in its strength and depth. We also note a perceived rising tide of informed market sentiment that appears to suggest quoted companies may realise a better reflection of their intrinsic valuations by moving their listing to North America. The US, specifically NASDAQ, provides an attractive option with its deep pool of life science capital markets.”
Just reread, it's says
In due course the company expects to relist on a regulated investment exchange that recognises the true underlying value of the business.
The US, specifically NASDAQ provide an allractrive option with deep pool of life science capital market.
You hold them for the long term and hope that the true valuation will be recognised away from AIM. Yet another Pharma company to delist from AIM.
As per the RNS no decisions on a re-list have been made yet, but we’re considering all options including NASDAQ where valuations are higher and liquidity isn’t a problem. We’re exploring putting a matched bargain facility (eg JP Jenkins) in place following delisting so that shareholders have the option to trade.
It may come goof for the company directors but definitely not for mere shareholders like myself who has just had £1,000 wiped off my pension pot. How do the shares recover from this?
OCTP is not AIM.
From recent experience with C4XD
You can keep your shares in a SIPP (or should be able to) to you cannot keep them if in an ISA.
OCTP will come good. Marathon not a sprint
Appreciate your reply BC2021. I never read the appendix as it was not showing on small tablet. Thanks for clearing up.
How do we trade shares on OTC once delisted from AIM if held in an ISA? Presumably the share value will still have fallen by the 70% experienced today, so what's the point? Going private seems to be a common course of action among AIM companies. It seems our best course of action is to sell all our AIM stocks sooner rather than later and stick to the FTSE companies, which is a shame.
Just bought 500,000 for £700 in SIPP
Here's hoping.
Would be much better
Potential future Nasdaq listing is mentioned in rns
Thats exactly what I intend to do. Its not said anything about a NASDAQ listing and not going to guess they do but no point in selling for me if what they say is true about being debt free.
No Elek. It’s being delisted from main market and going private. We could still potentially trade on the OTC but that’s dire. I will hold and hope they make a debut in the US one day.
It's not listing on AIM, they are taking shares off the market with a view to hopefully coming back on NASDAQ.
I don’t think so. I think they will look for investment and relist on Nasdaq ….
Apologies.
I misread as delisted.
Sorry for the mistake.
It’s going private
Not it’s not
Thank you 🙏
YES.